ADENTRA (ADEN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jul, 2026Executive summary
Achieved stable financial results in 2024 despite industry headwinds, including price pressures, high mortgage rates, and weakened building market demand.
Full-year sales reached $2.18 billion, down 2.5% year-over-year, while Q4 sales grew 3.1% to $530.8 million compared to Q4 2023.
Gross margin improved to 21.7% for both the year and Q4, up from 20.8% and 21.6% respectively in 2023.
Net income for 2024 increased 28.9% to $46.5 million, with basic EPS rising to $1.95 from $1.61 in 2023.
Completed $130 million acquisition of Woolf Distributing, expanding geographic reach and product portfolio.
Financial highlights
Q4 sales rose $16 million year-over-year to $530.8 million, driven by Woolf acquisition ($34.3 million contribution), offsetting a 3.4% organic sales decline.
Adjusted EBITDA for 2024 was $184.3 million, nearly flat year-over-year; Q4 Adjusted EBITDA was $42.2 million, down 5.1%.
Operating cash flow conversion rate was 82% in Q4, generating $34.9 million.
US operations generated $2.01 billion in sales, down 6% year-over-year, mainly due to product price deflation and lower volumes.
Canadian sales rose 3% to C$235.9 million, driven by higher volumes but offset by lower prices.
Outlook and guidance
Organic sales down 6% year-over-year in the first two months of Q1 2025, mainly due to lower volumes and adverse weather.
Market consensus for 2025 is a flat year for single-family and R&R, with multifamily expected to be weaker.
Pricing trends have stabilized; some product price inflation expected in 2025 due to tariffs.
90% of operations are US-based, with 92% of purchases not expected to be impacted by new tariffs.
Long-term housing fundamentals remain strong, with historic undersupply and favorable demographics supporting demand.
Latest events from ADENTRA
- 2025 sales and net income grew with strong cash flow and higher dividends despite market headwinds.ADEN
Q4 20258 Jul 2026 - Sales up 1.8% to $568.8M, net income up 28.7%, and leverage ratio at 2.5x after Woolf acquisition.ADEN
Q3 20248 Jul 2026 - Margin and earnings growth offset sales decline; acquisitions and cost controls drive outlook.ADEN
Q2 20248 Jul 2026 - Q1 2026 delivered organic sales growth but faced margin and earnings pressure amid macro headwinds.ADEN
Q1 20267 May 2026 - Directors and auditors were elected with strong support; no shareholder questions were raised.ADEN
AGM 20265 May 2026 - Sales up 1.4% from acquisition, but organic sales and earnings declined amid macro headwinds.ADEN
Q1 202527 Apr 2026 - Q3 sales rose 4.1% to $592.1M, with margin gains and strong cash flow despite market headwinds.ADEN
Q3 202527 Apr 2026 - Sustained growth, strategic acquisitions, and operational excellence drive long-term value creation.ADEN
Investor presentation16 Mar 2026 - Strong growth, disciplined M&A, and operational excellence drive double-digit returns.ADEN
Investor presentation16 Mar 2026